<DOC>
	<DOCNO>NCT00630188</DOCNO>
	<brief_summary>The purpose study determine whether intervention design help men share decision prostate cancer screen physician result good decision making , share decision , change intend actual screening rate .</brief_summary>
	<brief_title>Shared Decision Making Prostate Cancer Screening : Practice-Based Randomized Controlled Trial</brief_title>
	<detailed_description>Background : Professional society recommend share decision make prostate cancer screening , however , effort direct informed rather share decision making . In study , plan test effect share decision make intervention key component share decision making . We secondarily plan test effect presence share decision , men 's intention screen , actual screening rate . Methods : We plan conduct two separate randomize control trial share decision make intervention , one intervention focus prostate cancer screen one intervention focus prostate cancer screen context men 's health issue . Each trial use attention control identical implementation measurement strategy allow combination data difference exist effect intervention . Trials include convenience sample men prior history prostate cancer present primary care physician routine care . Men randomly assign share decision make intervention ( include video coaching session patient education session provider ) control group , men receive video highway safety . Data key component share decision make intent screening measure baseline , intervention , men 's visit provider . Additionally , medical chart review 9 month later assess actual screening .</detailed_description>
	<mesh_term>Prostatic Neoplasms</mesh_term>
	<criteria>Ages 4080 year Their physician agree participate study Seen practice least one year Prior history prostate cancer Presenting acute medical visit Nonskin cancer Lung disease require oxygen Renal failure require dialysis Intensive care visit last 6 month Need assistance activity daily live</criteria>
	<gender>Male</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>February 2008</verification_date>
	<keyword>prostate cancer screen</keyword>
	<keyword>share decision making</keyword>
	<keyword>prostate-specific antigen</keyword>
	<keyword>decision making</keyword>
	<keyword>physician-patient relation</keyword>
</DOC>